![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » RapidAI’s Neuroimaging Analysis Device Cleared
RapidAI’s Neuroimaging Analysis Device Cleared
The FDA has cleared RapidAI’s Rapid Aspects neuroimaging analysis device for assessing brain injuries in stroke patients.
The device uses a machine-learning algorithm to identify early signs of brain infarctions. It is the first neuroimaging analysis device to receive the agency’s computer-assisted diagnostic software clearance.
The neuroimaging device helps stroke teams quickly assess patient eligibility for blood clot removal, enabling faster triage and better patient outcomes, the company said.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct